We analyzed the association between HOTAIRM1 expression level with patient age, gender, tumor WHO clinical grade and found HOTAIRM1 expression level was related to tumor grade and was not related to age and gender (Table 1). This evidence concerns the gene HOTAIRM1 and neoplasm.